Bruce K. Lin
Impact in
- Cancer Research top 10%
- Carcinogens and Genotoxicity Assessment
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Glutathione Transferases and Polymorphisms 3
- Epigenetics and DNA Methylation 2
- Genomics, phytochemicals, and oxidative stress 1
- Oncology 4
- Cancer-related Molecular Pathways 2
- Co-authors
- Henry J. Lin (7 shared papers)Chun-Ya Han (4 shared papers)Steven Hardy (1 shared paper)Gordon T. Sakamoto (3 shared papers)Harold D. Frankl (3 shared papers)Eric R. Lee (3 shared papers)Nicole Probst‐Hensch (3 shared papers)Robert W. Haile (2 shared papers)
- Journals
- Carcinogenesis (2 papers)Nucleic Acids Research (1 paper)Pharmacogenetics (2 papers)PubMed (3 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Bruce K. Lin
8 papers receiving 659 citations
Peers
Comparison fields: 5 of 68
- Cancer Research 245
- Pharmacology 95
- Molecular Biology 463
- Pharmaceutical Science 33
- Oncology 126
Countries citing papers authored by Bruce K. Lin
This map shows the geographic impact of Bruce K. Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce K. Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce K. Lin more than expected).
Fields of papers citing papers by Bruce K. Lin
This network shows the impact of papers produced by Bruce K. Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce K. Lin. The network helps show where Bruce K. Lin may publish in the future.
Co-authors
The 17 scholars most cited alongside Bruce K. Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 153 | |
| 2 | Slow acetylator mutations in the human polymorphic N-acetyltransferase gene in 786 Asians, blacks, Hispanics, and whites: application to metabolic epidemiology. | 1993 | 146 |
| 3 | 1994 | 136 | |
| 4 | 1998 | 70 | |
| 5 | Acetylation polymorphism and prevalence of colorectal adenomas. | 1995 | 68 |
| 6 | 1996 | 60 | |
| 7 | Glutathione transferase (GSTM1) null genotype, smoking, and prevalence of colorectal adenomas. | 1995 | 42 |
| 8 | 1992 | 6 |
About Bruce K. Lin
Bruce K. Lin is a scholar working on Molecular Biology, Oncology, Cancer Research, Surgery and Urology, having authored 8 papers that have together received 681 indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (4 papers), Glutathione Transferases and Polymorphisms (3 papers), Cancer-related Molecular Pathways (2 papers), Epigenetics and DNA Methylation (2 papers), Chemical Reactions and Isotopes (1 paper), Lung Cancer Treatments and Mutations (1 paper), T-cell and Retrovirus Studies (1 paper) and Genomics, phytochemicals, and oxidative stress (1 paper). The work is most often cited by research in Cancer Research (245 citations), Pharmacology (95 citations), Molecular Biology (463 citations), Pharmaceutical Science (33 citations) and Oncology (126 citations). Bruce K. Lin has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Henry J. Lin, Chun-Ya Han, Steven Hardy, Gordon T. Sakamoto, Harold D. Frankl, Eric R. Lee, Nicole Probst‐Hensch, Robert W. Haile, Andrew D. Louie and Matthew P. Longnecker. Their work appears in journals such as Carcinogenesis, Nucleic Acids Research, Pharmacogenetics and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.